MorphoSys AG American Depositary Shares
MOR was delisted on the 2nd of August, 2024.
35 hedge funds and large institutions have $311M invested in MorphoSys AG American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$140M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$34.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$26.2M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$17.6M |
| 5 |
DM
Deerfield Management
New York
|
+$16.5M |
Top Sellers
MOR Hedge Fund Activity: Q2 2018 in Review
35 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q2 2018, worth a combined $311M.
Buyers outnumbered sellers: 35 funds opened new MOR positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $140M.
- 35 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $311M of MorphoSys AG American Depositary Shares stock for Q2 2018.
- 35 funds opened new MorphoSys AG American Depositary Shares positions in Q2 2018 and 0 closed out, a net change of +35 holders.
- The largest MorphoSys AG American Depositary Shares buyer in Q2 2018 was Fidelity Investments, an estimated $140M added.
Based on aggregated 13F filings for Q2 2018.